Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

142 trials with published results (10%)

Research Maturity

825 completed trials (56% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.2%

76 terminated out of 1463 trials

Success Rate

91.6%

+5.0% vs benchmark

Late-Stage Pipeline

12%

172 trials in Phase 3/4

Results Transparency

17%

142 of 825 completed with results

Key Signals

142 with results92% success76 terminated

Data Visualizations

Phase Distribution

1,001Total
Not Applicable (673)
Early P 1 (4)
P 1 (63)
P 2 (89)
P 3 (65)
P 4 (107)

Trial Status

Completed825
Unknown248
Recruiting157
Terminated76
Not Yet Recruiting70
Withdrawn39

Trial Success Rate

91.6%

Benchmark: 86.5%

Based on 825 completed trials

Clinical Trials (1463)

Showing 20 of 20 trials
NCT04968249Active Not RecruitingPrimary

Michigan Early Disease Progression Cohort

NCT03927820Not ApplicableCompletedPrimary

A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)

NCT06614959Not ApplicableCompletedPrimary

The Effects of Oscillatory Positive Expiratory Pressure (OPEP) Therapy in Patients With COPD

NCT07404826Not ApplicableRecruitingPrimary

PEP Buddy in Pulmonary Rehabilitation

NCT06935825RecruitingPrimary

Respiratory Muscles in End-stage Lung Disease: Pathophysiological Processes & Clinical Consequences

NCT07566195Phase 3Recruiting

Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations

NCT07567872Phase 1RecruitingPrimary

A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD

NCT07708337Not ApplicableNot Yet RecruitingPrimary

Evaluating Customized Antibiotic Duration (CDA) Strategy in Acute Exacerbations of COPD

NCT04754490CompletedPrimary

Exploring Breathing Patterns

NCT07707271Not ApplicableRecruitingPrimary

Continuous Versus High Intensity Interval Exercise in Chronic Obstructive Pulmonary Disease

NCT07707245Not ApplicableRecruitingPrimary

Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia

NCT07702994Not ApplicableNot Yet RecruitingPrimary

Effects of Adapted Snacktivity™ Intervention on Cognition and Self-Care in COPD Patients

NCT05181826Recruiting

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

NCT03256773Active Not Recruiting

High Resolution Micro OCT Imaging

NCT04212962Not ApplicableActive Not Recruiting

Transitional Care Model Evaluation 2020

NCT07686302Not ApplicableNot Yet RecruitingPrimary

Feasibility of Noninvasive Trigeminal Nerve Stimulation During Exercise

NCT06336252Not ApplicableCompletedPrimary

Technology Assisted Nudging to Increase Physical Activity Among Hospitalised Medical Patients

NCT05163600Not ApplicableRecruitingPrimary

The Acute Cardiorespiratory Response to Blood-flow Restricted Versus Traditional Exercise Training Regimens (CaRe BFR)

NCT05568043Not ApplicableCompletedPrimary

The Reducing REVISITS Study: A Cluster RCT

NCT07684391Not ApplicableNot Yet RecruitingPrimary

Effect of Oral Astaxanthin Formula on Pulmonary Rehabilitation in Patients With COPD

Scroll to load more

Research Network

Activity Timeline